Over the past few years, Dr. Helen Tremlett and her team have been evaluating population health data to establish a greater understanding of the relationship between MS drug treatments, comorbidities, and associated health outcomes. Most recently, her team, including post-doctoral fellow Dr. José Wijnands, has undergone a first-of-its-kind study to assess disease modifying treatments (DMTs) for multiple sclerosis (MS) and their relationship with infection risk in the ‘real world’ clinical setting.
Newsroom
For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.
- Email: emily.wight@brain.ubc.ca
- Phone: 604-417-0165
To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.
Most older adults are online, and many of them are using the internet to search for health-related information. But how easy to understand is the information they are finding, and who wrote it?
Newly rebranded as Neuroethics Canada, Dr. Illes’ team is looking to expand the scope of ethicists’ roles in Canada and move beyond the confines of academia and its communities.
Dr. Lara Boyd is recognized as one of BC's Most Influential Women by BC Business for her contributions as a leader in science in BC. Dr. Brian Kwon received a 2018 Apple Award from the American Spinal Injury Association for his publication Spinal cord perfusion pressure predicts neurologic recovery in acute spinal cord injury.
Heather Yong is a Directed Studies student in the Faculty of Medicine at the University of British Columbia. She has been volunteering with the UBC MS/NMO Clinic and Research Group at the Djavad Mowafaghian Centre for Brain Health since 2013.
For Canadian neuroscientists, the Canadian Open Neuroscience Platform (CONP) will make data collected through imaging, genome mapping, and other research methods accessible and easier to share with colleagues across the country, improving the odds of producing big discoveries as research data become available to more researchers.
New research from Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group suggests that for people with multiple sclerosis (MS), the presence of psychiatric comorbidities including depression, anxiety and mood disorders was associated with disability progression.
People who live in areas where they are exposed to more of the sun's rays, specifically UV-B rays, may be less likely to develop multiple sclerosis (MS) later in life, according to a study published in today in the journal Neurology. Exposure in childhood and young adulthood may also reduce risk.
Pictured: The Honourable Jody Wilson-Raybould (third from left), Minister of Justice and Member of Parliament, visits Dr. Cheryl Wellington's lab on a tour of DMCBH on October 13, 2017. Image credit: Paul Joseph.
Pictured: Dr. Brian MacVicar shows off the future home of the human brain imaging facility at the Djavad Mowafaghian Centre for Brain Health on a tour with MP Gordie Hogg and Dr. Vesna Sossi, Dr. Catharine Winstanley, Dr. Luke Clark, and UBC's Vice-President, Research & Innovation, Dr. Gail Murphy (February 21, 2018).
